Remnant epitopes generate autoimmunity: from rheumatoid arthritis and multiple sclerosis to diabetes.
暂无分享,去创建一个
Inge Nelissen | P. E. Van den Steen | G. Opdenakker | I. Nelissen | J. Van Damme | Philippe E Van den Steen | Ghislain Opdenakker | Jo Van Damme | Francis J Descamps | F. Descamps
[1] R. Dwek,et al. Glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin. , 1999, Biochemistry.
[2] T. Shimosegawa,et al. Pancreatic diabetes in Japan. , 1998, Pancreas.
[3] T. Tomita,et al. Gelatinases and inhibitors of gelatinases in pancreatic islets and islet cell tumors. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[4] W. Pangborn,et al. Phase changes in T(3)R(3)(f) human insulin: temperature or pressure induced? , 2001, Acta crystallographica. Section D, Biological crystallography.
[5] R. Dwek,et al. Glycosylation: heterogeneity and the 3D structure of proteins. , 1997, Critical reviews in biochemistry and molecular biology.
[6] G. Opdenakker,et al. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein. , 1993, Biochemical and biophysical research communications.
[7] L. Kotra,et al. N-Glycosylation pattern of the zymogenic form of human matrix metalloproteinase-9. , 2002, Bioorganic chemistry.
[8] C. Overall,et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. , 2000, Science.
[9] L. Fugger,et al. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263–270) in humanized transgenic mice and in rheumatoid arthritis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[10] G. Opdenakker,et al. Development and application of a radioimmunoassay for interleukin-8: detection of interleukin-8 in synovial fluids from patients with inflammatory joint disease. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[11] R. Dwek,et al. Glycosylation and the immune system. , 2001, Science.
[12] G. Opdenakker,et al. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. , 1991, European journal of biochemistry.
[13] P. E. Van den Steen,et al. Gelatinase B: a tuner and amplifier of immune functions. , 2001, Trends in immunology.
[14] A. Varki,et al. Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.
[15] M. Coletta,et al. Modulation of the Catalytic Activity of Neutrophil Collagenase MMP-8 on Bovine Collagen I , 2002, The Journal of Biological Chemistry.
[16] D. Wegmann,et al. Insulin‐specific T cells are a predominant component of islet infiltrates in pre‐diabetic NOD mice , 1994, European journal of immunology.
[17] S. Chandran,et al. Peripheral blood level alterations of TIMP‐1, MMP‐2 and MMP‐9 in patients with Type 1 diabetes , 2001, Diabetic medicine : a journal of the British Diabetic Association.
[18] R. Dwek,et al. Glycoforms modify the dynamic stability and functional activity of an enzyme. , 1994, Biochemistry.
[19] P. E. Van den Steen,et al. Gelatinase B is diabetogenic in acute and chronic pancreatitis by cleaving insulin , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] R. Sciot,et al. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. , 1999, The Journal of clinical investigation.
[21] P. E. Van den Steen,et al. Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post‐translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] D. Wegmann,et al. It's insulin. , 2000, Journal of autoimmunity.
[23] M. Lukic,et al. Effector Mechanisms in Low-Dose Streptozotocin-induced Diabetes , 1998, Developmental immunology.
[24] H. Mori,et al. Stepwise Movement of Preproteins in the Process of Translocation across the Cytoplasmic Membrane of Escherichia coli(*) , 1995, The Journal of Biological Chemistry.
[25] A. Rossini,et al. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. , 1976, Science.
[26] T. Nakamura,et al. Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] R. Dwek,et al. O-glycan analysis of natural human neutrophil gelatinase B using a combination of normal phase-HPLC and online tandem mass spectrometry: implications for the domain organization of the enzyme. , 2000, Biochemistry.
[28] G. Opdenakker,et al. Cytokine-regulated proteases in autoimmune diseases. , 1994, Immunology today.
[29] H. Iguchi,et al. Clinical assessment of pancreatic diabetes caused by chronic pancreatitis , 1998, Journal of Gastroenterology.
[30] R. Dwek,et al. Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition , 1995, European journal of immunology.
[31] G. Schneider,et al. Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. , 1999, Science.
[32] R. Dwek,et al. Cells regulate the activities of cytokines by glycosylation , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] R. Dwek,et al. Oligosaccharides of recombinant mouse gelatinase B variants. , 1998, Biochimica et biophysica acta.
[34] R. Dwek,et al. Recognition of carbohydrate by major histocompatibility complex class I- restricted, glycopeptide-specific cytotoxic T lymphocytes , 1994, The Journal of experimental medicine.
[35] E. Unanue,et al. Distinct recognition by two subsets of T cells of an MHC class II-peptide complex , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[36] R. Dwek,et al. Matrix remodelling enzymes, the protease cascade and glycosylation. , 2001, Biochimica et biophysica acta.
[37] R. Dwek,et al. Concepts and principles of O-linked glycosylation. , 1998, Critical reviews in biochemistry and molecular biology.
[38] R. Dwek,et al. The Activation of Type 1 and Type 2 Plasminogen by Type I and Type II Tissue Plasminogen Activator (*) , 1995, The Journal of Biological Chemistry.
[39] E. Baker,et al. Structure of Rhombohedral 2 Zinc Insulin Crystals , 1969, Nature.
[40] P. E. Van den Steen,et al. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. , 2000, Blood.